PATENT CLAIM ANALYSIS

Application Number: 16143995
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["424", "133100"]

Abstract:
The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccine and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies.

Claim (Index 21):
The antibody of  claim 14 , wherein the antibody is capable of causing dendritic cells activated with GM-CSF and Interferon alpha to secrete at least one of IL-6, MIP-1a, IP-10, IL-10 or IL-12p40.

Metadata:
- Claim Count in Document: 37.0
- Percentile: 97.0
- Lexical Diversity: 1.61364
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12718365', '14165400', '15401856', '12717778', '12717789']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8278220358512243
- 35 USC 102 Novelty (BERT): 0.6886149335813084
- Combined Prediction Score: 0.8139013256242327
- Mean Citation Score: 657.786522
- Max Citation Score: 712.34326
- Similarity Product: 683.9605020544326

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test